Skip To Main Content
{ "isEditMode": false, "isPublic": true, "context": "", "site": "campus-sanofi-cz", "currentLocale": "cs_CZ", "translationsPath": "", "cfViewerCountry": "US" }
[{ event: `metadata`,device: /(tablet|ipad|playbook|silk)|(android(?!.*mobi))/i.test(navigator.userAgent) ? 'tablet' : (/Mobile|iP(hone|od)|Android|BlackBerry|IEMobile|Kindle|Silk-Accelerated|(hpw|web)OS|Opera M(obi|ini)/.test(navigator.userAgent) ? 'mobile' : 'desktop'),platform: `magnolia`,language: `cs`,siteType: `advise`,brandWebsiteType: `multibrand`,region: `emea`,country: `czech republic`,target: `hcp`,brand: `Multi-Brand`,gbu: `GBU - Specialty care`,pageName: `Transplantační medicína` }, { event: `promomat_metadata` }]
Určeno pro odbornou veřejnost
Campus
Věda
Podpora Pacienta
Produkty
Farmakovigilance
Přihlásit se
Registrovat se
Campus
Věda
Podpora Pacienta
Produkty
Farmakovigilance
Přihlásit se
Registrovat se
Search Term
View Full Results
Transplantační medicína
Nejnovější trendy
Prozkoumejte nejčtenější články a videa na Campus Sanofi
Seřadit
Nejnovější
Nejstarší
Abecedně
ASMD Phenotypes
Číst více
ASMD Phenotypes
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?
Číst více
«
‹
671
672
673
674
675
676
677
678
679
680
›
»